DFIB Cardiac Science (MM)

More Than 97,000 People Attending Church Events Weekly IRVINE, Calif., Aug. 18 /PRNewswire-FirstCall/ -- Cardiac Science, Inc. (NASDAQ:DFIB), a leading manufacturer of life-saving public-access defibrillators (AEDs), announced today that the Catholic Diocese of Fort Worth, Texas has completed deploying Powerheart(R) AEDs in all its facilities, including 90 parishes, 19 schools and other Diocesan locations throughout 28 North Central Texas counties covering more than 23,000 square miles. Peter Flynn, Director of Finance and Administrative Services for the Diocese, said the selection of the Powerheart AEDs came after a thorough review of AEDs available in the marketplace. "Our objective was to have life-saving AED equipment available to protect more than 97,000 parishioners who attend Mass each week and nearly 7,000 students who attend school daily," Flynn said. "When deciding which AED to purchase, our selection committee looked at reliability, ease of use and multilingual capabilities as our primary criteria. The Powerheart device fulfilled what we were looking for and Cardiac Science's reputation for reliability and service closed the deal." Flynn added, "We want every person who attends an event or Mass in any facility owned by the Diocese of Fort Worth to know that we are concerned for their safety and prepared to act in a medical emergency. Having an AED available is an important part of helping us reach this goal." Cardiac Science Chairman and CEO Raymond W. Cohen said, "The leadership of the Catholic Diocese of Fort Worth should be recognized for being proactive in protecting their congregation against cardiac arrest. Over one hundred AEDs, which we shipped at the end of June, were deployed in North Texas churches and schools this summer. We believe this order represents the single largest deployment of AEDs to date to a religious organization in America and is indicative of yet another new and significant market segment which we anticipate will continue to be further penetrated in for the months and years to come." About the Diocese of Fort Worth The Diocese of Fort Worth was established in 1969 after being part of the Diocese of Dallas for almost 80 years. At present, the Diocese has more than 400,000 Catholics in 90 parishes served by 113 priests, 62 deacons, 93 sisters, and 13 brothers. It is made up of 28 counties of North Central Texas: Archer, Baylor, Bosque, Clay, Comanche, Cooke, Denton, Eastland, Erath, Foard, Hardeman, Hill, Hood, Jack, Johnson, Knox, Montague, Palo Pinto, Parker, Shackelford, Somervell, Stephens, Tarrant, Throckmorton, Wichita, Wilbarger, Wise, and Young with a total of 23,950 square miles. About Cardiac Science Cardiac Science develops, manufactures and markets a complete line of Powerheart(R) brand, automatic public access defibrillators (AEDs), and offers comprehensive AED/CPR training and AED program management services that facilitate successful deployments. Cardiac Science also manufactures its AED products on a private label basis for other leading medical companies such as Nihon Kohden (Japan), Quinton Cardiology Systems and GE Healthcare. For more information please visit http://www.cardiacscience.com/ or call 1.949.797.3800. This press release includes forward-looking statements. These statements may be identified by the use of forward-looking terminology such as "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "might," "plan," "potential," "predict," "should," or "will," or the negative thereof or other variations thereon or comparable terminology. Cardiac Science has based these forward-looking statements on the current expectations, assumptions, estimates and projections. While Cardiac Science believes the Fort Worth Diocese deployment to be a benefit to its parishioners and will save lives, these expectations, assumptions, estimates and projections, while reasonable, are forward-looking statements and are only predictions and involve known and unknown risks and uncertainties, many of which are beyond our control. Certain factors, including those discussed in Cardiac Sciences' Annual Report on Form 10-K for the year ended December 31, 2004, under the heading "Risk Factors," may cause the actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by these forward-looking statements. Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements. We do not undertake any obligation to update any such statements or to publicly announce the results of any revisions to any such statements to reflect future events or developments. Contact: Matt Clawson (Investors) Michael D. Gioffredi Len Hall (Media) Chief Marketing Officer Allen & Caron Inc Cardiac Science, Inc. (949) 474-4300 (949) 797-3800 DATASOURCE: Cardiac Science, Inc. CONTACT: Investors, Matt Clawson, , or Media, Len Hall, , both of Allen & Caron Inc, +1-949-474-4300, for Cardiac Science, Inc.; or Michael D. Gioffredi, Chief Marketing Officer of Cardiac Science, Inc., +1-949-797-3800, Web site: http://www.cardiacscience.com/

Copyright